Community-based Intervention to Prevent Intimate Partner Violence in Rural Southwest, Nigeria

October 31, 2023 updated by: Funmilola OlaOlorun

A Community-based Intervention to Address Social Norms Associated With Intimate Partner Violence in Rural Southwest, Nigeria

Background:

Intimate partner violence is arguably the most prevalent, persistent and pernicious type of violence against women, all around the world. It also has significant repercussions for women's health, yet, in some parts of the world, considered an acceptable practice within intimate partner relationships. Community-based interventions, on the other hand, offer promises as a strategy that can get community members involved in working to prevent IPV. This study evaluated a community mobilisation intervention to challenge attitudes toward IPV and prevent violence within intimate relationships.

Methods:

This mixed-method randomised community trial was conducted in selected rural communities in Oyo State, Nigeria, between January 2018 and April 2021. It employed a six-month community mobilisation intervention focused on creating awareness and challenging harmful social norms relating to IPV. In-depth interviews, focus group discussions and two cross-sectional surveys were conducted among men and women of reproductive age who were married at baseline and end line to estimate changes in key outcomes. Difference-in-difference regression models were estimated to compare changes in IPV levels in the intervention and control arms.

Conclusion:

This trial should demonstrate the effectiveness of community mobilisation interventions to change attitudes supportive of IPV and prevent women's experience of IPV.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Background: Intimate partner violence (IPV) is arguably the most pernicious, pervasive, and persistent form of violence against women worldwide. It is an abuse of women's fundamental human rights and a public health concern. Experience of IPV by women has been associated with a mixture of both noticeable and frequently unnoticed outcomes, negatively affecting their health and wellbeing.

The prevalence of IPV is high in sub-Saharan Africa, where it is considered an element of the unwritten rules underpinning intimate relationships. Interventions that challenge these social norms are still evolving; community mobilization interventions, on the other hand, offer some potential in moderating the attitudes that permit or promote IPV. This study evaluated the effect of a community mobilization intervention on attitudes toward social norms that influence IPV in selected rural communities of Oyo State, Nigeria.

Methods: In a randomised community trial conducted in 8 rural communities of Oyo State, Nigeria, a six-month community mobilization intervention that consisted of advocacy to stakeholders, community workshops and small group discussions in 6 selected communities was tested compared with no intervention in the 2 control communities.

To engender community participation and sustainability of the intervention the investigator recruited and trained members of the community as 'Model Couples'. Community leaders, community health workers were also engaged to speak against IPV. Both the 'Model couples' and community leaders addressed topics like gender and power dynamics, IPV and its consequences, law prohibiting all forms of violence against women, social norms that influence IPV, and need to take action for change.

The intervention was tested among women of reproductive age, using a convergent parallel mixed-methods design. The study outcomes were attitudes toward social norms associated with IPV and experience of IPV. For the collection of quantitative data, a modified WHO women's health questionnaire was used, while an interview guide was developed for the collection of the qualitative data.

Conclusion: This trial should show community mobilization intervention as a strategy that can reduce women's experience of IPV and change attitudes toward IPV.

Study Type

Interventional

Enrollment (Actual)

2650

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Oyo State
      • Ibadan, Oyo State, Nigeria
        • Oriire LGA

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Men aged 18 to 59 years
  • Women aged 18 to 49 years
  • Currently married or cohabiting with a partner
  • had lived in the community for a minimum of one year.

Exclusion Criteria:

  • Married/ cohabiting males or females
  • does not speak either Yoruba or English

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: No intervention
Experimental: Community mobilization
a six-month community mobilization intervention that consisted of advocacy to stakeholders, community workshops and small group discussions in intervention communities
The intervention focused on creating awareness, challenging social norms, and promoting actions against violence. To achieve these, the following activities were undertaken: introductory meetings, selection and training of model couples, structured workshops and small group meetings.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Attitudes towards social norms around intimate partner violence
Time Frame: One year before the survey
Respondent agreed that a man is justified to beat his wife in seven scenarios provided. A score of 0 showed not supportive of physical IPV, while a score of 1 -7 showed attitude supportive of IPV
One year before the survey

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Experience of intimate partner violence
Time Frame: One year before the survey
Respondent answered yes to being physically, emotionally or sexually abused. A score of 0 showed no experience of IPV but a sore of more than 0 showed experience of IPV
One year before the survey
Perpetration of intimate partner violence
Time Frame: One year before the survey
Respondent answered yes to physically, emotionally or sexually abusing his wife. A score of 0 showed no perpetration of IPV but a sore of more than 0 showed perpetration of IPV
One year before the survey
Community response to women's experience of of intimate partner violence
Time Frame: One year
Community member agreed to intervening when they witnessed violence between couple
One year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 12, 2021

Primary Completion (Actual)

August 1, 2021

Study Completion (Actual)

December 1, 2022

Study Registration Dates

First Submitted

October 7, 2023

First Submitted That Met QC Criteria

October 31, 2023

First Posted (Actual)

November 7, 2023

Study Record Updates

Last Update Posted (Actual)

November 7, 2023

Last Update Submitted That Met QC Criteria

October 31, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • SNIP Project

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Domestic Violence

Clinical Trials on Community mobilization

Subscribe